Julien P N Papillon
4PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 09, 2026
Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease Inhibitor.Julien P N Papillon, Jun Yuan, Matthew J Hesse
|Jan 10, 2024
Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma.Michael Visser, Julien P N Papillon, Michael Luzzio
|Aug 05, 2020
The Discovery of SWI/SNF Chromatin Remodeling Activity as a Novel and Targetable Dependency in Uveal Melanoma.Florencia Rago, GiNell Elliott, Ailing Li
|Oct 20, 2018
Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers.Julien P N Papillon, Katsumasa Nakajima, Christopher D Adair
Pageof 1
Frequent Collaborators
1 joint publications
Katsumasa Nakajima
1 joint publications
Julie T Chen
1 joint publications
Matthew D Shirley
1 joint publications
Anthony Vattay
1 joint publications
Michael Visser
1 joint publications
Matthew J LaMarche
1 joint publications
Rosemary Barrett
1 joint publications
Matthew J Hesse
1 joint publications
Lei Zhang
1 joint publications
Richard I Robinson
